5 Recruiting Plaque Psoriasis Phase 2 Clinical Trials
Active phase 2 studies for plaque psoriasis enrolling across the USA. Verify eligibility and contact site coordinators.
All Plaque Psoriasis studiesPhase 2 Studies for Plaque Psoriasis
🔵 Active, Not Recruiting Phase2
Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis
📍 Oruka Therapeutics Investigative Site — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis
📍 Investigator Site # 1029 — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis
📍 Oruka Therapeutics Investigative Site — Fountain Valley, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
📍 Oruka Therapeutics Investigative Site — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
📍 Oruka Therapeutics Investigative Site — Fountain Valley, California
View Study & Checklist ➔